 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Blood glucose, antidiabetic drugs, and risk of stroke |
| Meng Lee, Bruce Ovbiagele |
|
Precis Future Med. 2021;5(1):13-20. Published online March 2, 2021 DOI: https://doi.org/10.23838/pfm.2020.00156 |
|
Blood glucose, antidiabetic drugs, and risk of stroke Precision and Future Medicine. 2021;5(1):13-20  Repaglinide – prandial glucose regulator: a new class of oral antidiabetic drugs Diabetic Medicine. 1998;15(S4):S28-S36 Glucose-sensitive materials for delivery of antidiabetic drugs Engineering Drug Delivery Systems. 2020;203-228 Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs Cardiovascular Drugs and Therapy. 2014;28(4):331-334 Effect of Oral Antidiabetic Drugs on Blood-Sugar and Inorganic Phosphate Curves in Oral and Intravenous Glucose-Tolerance Tests.1 Acta Medica Scandinavica. 2009;160(1):67-74 Antidiabetic drugs and stroke risk. Current evidence European Journal of Internal Medicine. 2018;48:1-5 Measurement of Blood Glucose-Lowering and Antidiabetic Activity Drug Discovery and Evaluation: Pharmacological Assays. 2015;1-39 Measurement of Blood Glucose-Lowering and Antidiabetic Activity Drug Discovery and Evaluation: Pharmacological Assays. 2016;2623-2656 Clinical Trial for Antidiabetic Drugs: FDA Guidance for Diabetes Mellitus-Evaluation of Cardiovascular Risk in New Antidiabetic Therapies Journal of Korean Diabetes. 2011;12(3):129 Repaglinide – prandial glucose regulator: a new class of oral antidiabetic drugs Diabetic Medicine. 1998;15(S4):S28-S36 |
